{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:49:54Z","timestamp":1760575794887,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jfma.2020.08.001","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T17:18:53Z","timestamp":1598289533000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P1","title":["Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis"],"prefix":"10.1016","volume":"120","author":[{"given":"Chin-Chen","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Shuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3384-873X","authenticated-orcid":false,"given":"Yi-Hong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Kuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Hua","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3114-582X","authenticated-orcid":false,"given":"Ching-Chu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-0716","authenticated-orcid":false,"given":"Leay Kiaw","family":"Er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2020.08.001_bib1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2020.08.001_bib2","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2020.08.001_bib3","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib4","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2020.08.001_bib6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/000313480507101015","article-title":"Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature","volume":"71","author":"Lumachi","year":"2005","journal-title":"Am Surg"},{"key":"10.1016\/j.jfma.2020.08.001_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.ajkd.2009.06.014","article-title":"Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma","volume":"54","author":"Group","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2020.08.001_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ecl.2011.01.005","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"40","author":"Rossi","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jfma.2020.08.001_bib9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism \u2013 the consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.08.001_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jfma.2018.01.006","article-title":"Targeted treatment of primary aldosteronism \u2013 the consensus of Taiwan Society of Aldosteronism","volume":"118","author":"Huang","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.08.001_bib11","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2020.08.001_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2020.08.001_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2020.08.001_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","article-title":"Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension","volume":"18","author":"Nishizaka","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","article-title":"Commentary on the endocrine society practice guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism","volume":"12","author":"Fischer","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jfma.2020.08.001_bib16","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/EJE-17-0990","article-title":"Management of endocrine disease: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited","volume":"179","author":"Williams","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2020.08.001_bib17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","article-title":"The diagnosis of primary aldosteronism and separation of two major subtypes","volume":"153","author":"Weinberger","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2020.08.001_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2020.08.001_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jch.12523","article-title":"Unadjusted plasma renin activity as a \"First-Look\" test to decide upon further investigations for primary aldosteronism","volume":"17","author":"Rye","year":"2015","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"year":"2019","series-title":"Williams textbook of endocrinology","author":"Melmed","key":"10.1016\/j.jfma.2020.08.001_bib21"},{"key":"10.1016\/j.jfma.2020.08.001_bib22","first-page":"87","article-title":"Effects of potassium on renin and aldosterone","volume":"77","author":"Kotchen","year":"1984","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.jfma.2020.08.001_bib23","first-page":"e513","article-title":"Hypokalemia may mask primary aldosteronism: a case series","volume":"4","author":"Morkos","year":"2018","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.jfma.2020.08.001_bib24","first-page":"39","article-title":"Laboratory investigation of primary aldosteronism","volume":"31","author":"Stowasser","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jfma.2020.08.001_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrendo.2011.180","article-title":"A diagnostic algorithm--the holy grail of primary aldosteronism","volume":"7","author":"Rossi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jfma.2020.08.001_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jfma.2020.08.001_bib27","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/jc.2011-2504","article-title":"Confirmatory testing in primary aldosteronism","volume":"97","author":"Nanba","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2020.08.001_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005574","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the aldosterone-renin ratio for primary aldosteronism (AQUARR) study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2020.08.001_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tem.2005.02.006","article-title":"Plasma renin and aldosterone measurements in low renin hypertensive states","volume":"16","author":"Sealey","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib31","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/HJH.0b013e32833d2192","article-title":"The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma","volume":"28","author":"Rossi","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/HJH.0000000000000076","article-title":"Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension","volume":"32","author":"Lonati","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib33","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jfma.2020.08.001_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316657450","article-title":"Aldosterone\/direct renin concentration ratio as a screening test for primary aldosteronism: a meta-analysis","volume":"17","author":"Li","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jfma.2020.08.001_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0029-1246186","article-title":"Confirmatory tests in the diagnosis of primary aldosteronism","volume":"42","author":"Mulatero","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2020.08.001_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2020.08.001_bib38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cen.13943","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a systematic review and meta-analysis","volume":"90","author":"Wu","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jfma.2020.08.001_bib39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2017-01530","article-title":"Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism","volume":"103","author":"Meng","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib40","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41440-019-0247-1","article-title":"The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism","volume":"42","author":"Saiki","year":"2019","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jfma.2020.08.001_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2020.08.001_bib42","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/jc.2014-2788","article-title":"Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy","volume":"99","author":"Haase","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib43","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00270-017-1637-x","article-title":"Adrenal vein sampling for primary aldosteronism: a 2-week protocol for withdrawal of renin-stimulating antihypertensives","volume":"40","author":"Ching","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jfma.2020.08.001_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/jc.2018-01299","article-title":"Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism","volume":"104","author":"Nanba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib45","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jc.2018-01324","article-title":"Adrenal venous sampling with or without adrenocorticotropic hormone stimulation: a meta-analysis","volume":"104","author":"Laurent","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib46","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/HJH.0000000000001964","article-title":"Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism","volume":"37","author":"Takeda","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib47","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism","volume":"101","author":"El Ghorayeb","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2020.08.001_bib48","doi-asserted-by":"crossref","first-page":"D15","DOI":"10.1530\/EJE-18-0844","article-title":"Adrenal venous sampling: cosyntropin stimulation or not?","volume":"181","author":"Deinum","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2020.08.001_bib49","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1530\/EJE-11-0972","article-title":"A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism","volume":"166","author":"Seccia","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2020.08.001_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/EJE-16-0701","article-title":"Adrenal vein sampling in primary aldosteronism: concordance of simultaneous vs sequential sampling","volume":"176","author":"Almarzooqi","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2020.08.001_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/HJH.0000000000001564","article-title":"The subtyping of primary aldosteronism by adrenal vein sampling: sequential blood sampling causes factitious lateralization","volume":"36","author":"Rossitto","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib52","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1007\/s00330-019-06209-5","article-title":"Simultaneous bilateral adrenal vein sampling for primary aldosteronism: useful tips to make it simple and safe","volume":"29","author":"Lupi","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jfma.2020.08.001_bib53","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1038\/s41598-018-20647-z","article-title":"The influence of the peripheral cortisol fluctuation on the success rate of adrenal venous sampling","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2020.08.001_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MED.0000000000000407","article-title":"Update in adrenal venous sampling for primary aldosteronism","volume":"25","author":"Rossi","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jfma.2020.08.001_bib55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-7061(01)02312-3","article-title":"Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning","volume":"15","author":"Mansoor","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jfma.2020.08.001_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EC-14-0086","article-title":"Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism","volume":"3","author":"Sonoyama","year":"2014","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jfma.2020.08.001_bib57","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00259-014-2692-z","article-title":"Prognostic value of semiquantification NP-59 SPECT\/CT in primary aldosteronism patients after adrenalectomy","volume":"41","author":"Lu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jfma.2020.08.001_bib58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620303557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620303557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:45:02Z","timestamp":1760539502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664620303557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0929664620303557"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.08.001","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}